Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Carcinoma, Ovarian Epithelial 5Ovarian Neoplasms 4Endometrial Neoplasms 3Testicular Neoplasms 2Teratoma 2Fallopian Tube Neoplasms 2Central Nervous System Neoplasms 2Breast Neoplasms 2Wilms Tumor 1Uterine Cervical Neoplasms 1Testicular Germ Cell Tumor 1Seminoma 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Ovarian Germ Cell Cancer 1Osteosarcoma 1Optic Nerve Glioma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroblastoma 1Medulloblastoma 1Liver Neoplasms 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Eosinophilic, Acute 1Leukemia 1Kidney Neoplasms 1Familial ependymoma 1Endometrial Adenocarcinoma 1Endodermal Sinus Tumor 1

Interventions

Paclitaxel 5Ifosfamide 5Filgrastim 5Etoposide 3Cisplatin 3Carboplatin 3pegfilgrastim 2liposomal amphotericin B 2Therapeutics 2Granulocyte Colony-Stimulating Factor 2sargramostim 1ixabepilone 1aldesleukin 1Thiotepa 1Taxes 1Surgical Procedures, Operative 1Sunitinib 1Ribavirin 1Radiotherapy 1Psychiatric Rehabilitation 1Peripheral Blood Stem Cell Transplantation 1Palivizumab 1Nivolumab 1Mesna 1Lenograstim 1Itraconazole 1Ipilimumab 1Interleukin-12 Subunit p35 1Interleukin-11 1Interferon-alpha 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Endodermal Sinus Tumor × ixabepilone × Gynecologic × Clear all
NCT00070096 2013-06-24

Ixabepilone in Treating Patients With Advanced Cisplatin-Refractory Germ Cell Tumors

National Cancer Institute (NCI)

Phase 2 Completed
29 enrolled
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡